Section Arrow
EVMN.NYSE
- Evommune Inc.
Quotes are at least 15-min delayed:2026/08/01 11:22 EDT
Regular Hours
Last
 11.25
-0.1 (-0.88%)
Day High 
11.37 
Prev. Close
11.35 
1-M High
14.11 
Volume 
302.97K 
Bid
7
Ask
11.66
Day Low
10.8 
Open
11.34 
1-M Low
10.47 
Market Cap 
408.81M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.51 
20-SMA 12.1 
50-SMA 17.46 
52-W High 33.2 
52-W Low 10.47 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.11/-2.52
Enterprise Value
410.28M
Balance Sheet
Book Value Per Share
8.46
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
13.00M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.